This site is intended for health professionals only
Wednesday 20 September 2017
Share |

Levemir® receives positive CHMP opinion for extended use in children as young as one year old

There are an estimated 497,100 children living with type I diabetes globally and incidence is increasing in many countries. (1) Young children with type I diabetes can be difficult to treat as their needs are in constant flux during growth and development, (2) with children aged six and under at greatest risk of severe hypoglycaemia and acute diabetes complications. (3)

Ads by Google